Quent Capital LLC Has $200,000 Stock Holdings in Corteva, Inc. (NYSE:CTVA)

Quent Capital LLC raised its stake in Corteva, Inc. (NYSE:CTVA) by 5.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,510 shares of the company’s stock after acquiring an additional 182 shares during the period. Quent Capital LLC’s holdings in Corteva were worth $200,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Hager Investment Management Services LLC acquired a new position in shares of Corteva during the 4th quarter worth $27,000. Golden State Wealth Management LLC acquired a new position in shares of Corteva during the 4th quarter worth $32,000. Capital Advisors Ltd. LLC raised its holdings in shares of Corteva by 44.4% during the 3rd quarter. Capital Advisors Ltd. LLC now owns 566 shares of the company’s stock worth $33,000 after buying an additional 174 shares in the last quarter. First Financial Corp IN acquired a new position in shares of Corteva during the 4th quarter worth $35,000. Finally, Albion Financial Group UT raised its holdings in shares of Corteva by 112.6% during the 4th quarter. Albion Financial Group UT now owns 606 shares of the company’s stock worth $35,000 after buying an additional 321 shares in the last quarter. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Trading Down 1.5 %

NYSE CTVA opened at $62.02 on Thursday. The business’s 50-day moving average price is $60.24 and its two-hundred day moving average price is $58.35. Corteva, Inc. has a 12 month low of $50.01 and a 12 month high of $66.24. The firm has a market capitalization of $42.63 billion, a PE ratio of 48.08, a price-to-earnings-growth ratio of 1.85 and a beta of 0.78. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.08.

Corteva (NYSE:CTVA) last announced its earnings results on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. On average, analysts expect that Corteva, Inc. will post 2.83 EPS for the current year.

Corteva announced that its Board of Directors has approved a stock repurchase plan on Tuesday, November 19th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 7.5% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s board of directors believes its shares are undervalued.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 3rd will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $0.68 annualized dividend and a dividend yield of 1.10%. Corteva’s payout ratio is 52.71%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on CTVA. Citigroup boosted their price target on Corteva from $69.00 to $74.00 and gave the stock a “buy” rating in a report on Wednesday, January 29th. Wells Fargo & Company boosted their price target on Corteva from $67.00 to $73.00 and gave the stock an “overweight” rating in a report on Tuesday, January 28th. Barclays boosted their price objective on Corteva from $62.00 to $64.00 and gave the stock an “equal weight” rating in a research report on Tuesday, January 21st. Oppenheimer boosted their price objective on Corteva from $70.00 to $72.00 and gave the stock an “outperform” rating in a research report on Friday, February 7th. Finally, UBS Group reduced their price objective on Corteva from $74.00 to $73.00 and set a “buy” rating on the stock in a research report on Friday, January 10th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $67.73.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.